A phase II trial of pemetrexed plus gemcitabine as first-line treatment for locally advanced or metastatic transitional cell carcinoma of the urothelium
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4592-4592
◽
Keyword(s):
Phase Ii
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. e15087-e15087
◽
2013 ◽
Vol 71
(4)
◽
pp. 1033-1039
◽
Keyword(s):